Merck HCV: MRL Smoke and BS

Anonymous

Guest
Listened to our EASL review T-C a few weeks back. Outside vendor informed us on all the new molecules being brought through phase II into phase III by Gilead, BI, Tibotec ect.. Not a word on Merck's 5172. Not a word on Merck finding another agent to partner 5172 with. Does this mean we will be fourth guy on the block and have no second agent to co-formulate with ?